Therefore, urinary TIMP-2 × IGFBP-7 examination may offer additional benefits regarding short-term mortality in the general population of patients visiting the ED, in contrast to patients with sepsis and a high incidence of AKI. This evidence concerns the gene IGFBP7 and acute kidney injury.